clinical trial · NCT04504760
Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and PK of ONO-2910 in Japanese and Caucasian Subjects
Ono Pharmaceutical Co., Ltd.·phase1·completed·n = 80
Healthy VolunteersONO-2910PlaceboONO-2910Placebo
brief summary
To investigate safety, tolerability and pharmacokinetics in Japanese and Caucasian subjects when ONO-2910 is administered as single and multiple doses orally.
started
Jul 10, 2020
primary completion
Mar 18, 2021
completion
Mar 18, 2021
last updated
May 3, 2024
detailed description
This study is the First in Human (FIH) study to investigate safety, tolerability and pharmacokinetics in healthy Japanese and Caucasian adult male subjects when ONO-2910 is administered as single and multiple doses orally. Also, the purpose of this study is to evaluate pharmacokinetics of oral single-dose of ONO-2910 in Japanese elderly male and female subjects.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol